ADAM15 and colorectal carcinoma: In addition, we revealed that serum ADAM15 concentrations were significantly higher in CRC patients with the presence of distant metastasis (M1 subgroup) in comparison to the M0 subgroup (p = 0.043), similar to the CEA (p = 0.21) and CRP (p = 0.004) levels (Table 4).